Bachem Holding (Suzhou): difference between revisions
Diff·revision 35 → 36·00:54, 2 Apr 2025
Difference between revision 35 and revision 36 of Bachem Holding (Suzhou). 4 lines changed; the page grew by 363 bytes.
| Revision 35 — 02:05, 26 Mar 2025 GlossaryGleb (talk) rm citation to a supplier's own page 7,831 bytes +94 | Revision 36 — 00:54, 2 Apr 2025 StubSorterBot (talk) bot: flag bare reference 8,194 bytes +363 | ||
|---|---|---|---|
| 55 | The set includes one report on a sequence for which no [[Reference standard|certified reference standard]] is commercially available. A purity figure obtained without a qualified standard is a statement about relative peak areas and cannot be converted into a potency; that limitation applies to the report and not to the material.{{r|usp1503,iso17025}} | 55 | The set includes one report on a sequence for which no [[Reference standard|certified reference standard]] is commercially available. A purity figure obtained without a qualified standard is a statement about relative peak areas and cannot be converted into a potency; that limitation applies to the report and not to the material.{{r|usp1503,iso17025}} |
| 56 | 56 | ||
| + | 57 | == Reception == | |
| + | 58 | The PeptidePedia tally records 838 self-reported submissions to July 2026 — among the higher figures on the wiki. Recurring positive themes are certificate completeness and consistency across orders; recurring complaints concern the name confusion.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| + | 59 | ||
| 57 | == References == | 60 | == References == |
| 58 | {{reflist}} | 61 | {{reflist}} |
| ⋮ | ⋮ | ||
| 72 | * [[Peptide content]] | 75 | * [[Peptide content]] |
| 73 | * [[Research use only]] | 76 | * [[Research use only]] |
| + | 77 | * [[Peptide supply chain]] | |
| 74 | 78 | ||
| 75 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 79 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |